These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 3264190

  • 1. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
    Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, Abbink JJ, Strack van Schijndel RJ, Felt-Bersma RJ, Thijs LG, Hack CE.
    Blood; 1988 Dec; 72(6):1841-8. PubMed ID: 3264190
    [Abstract] [Full Text] [Related]

  • 2. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH, Huijbregts CC, Cohen M, Navis GO, de Vries A, Eerenberg AJ, Bakker JC, Hack CE.
    Thromb Haemost; 1987 Aug 04; 58(2):778-85. PubMed ID: 2445044
    [Abstract] [Full Text] [Related]

  • 3. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP, Joseph K.
    Adv Immunol; 2014 Aug 04; 121():41-89. PubMed ID: 24388213
    [Abstract] [Full Text] [Related]

  • 4. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
    Kaplan AP, Gruber B, Harpel PC.
    Blood; 1985 Sep 04; 66(3):636-41. PubMed ID: 3875374
    [Abstract] [Full Text] [Related]

  • 5. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G, Janssen-Claessen T, Rosing J, Griffin JH.
    Eur J Biochem; 1987 May 04; 164(3):637-42. PubMed ID: 3552674
    [Abstract] [Full Text] [Related]

  • 6. Proteolytic inactivation of plasma C1- inhibitor in sepsis.
    Nuijens JH, Eerenberg-Belmer AJ, Huijbregts CC, Schreuder WO, Felt-Bersma RJ, Abbink JJ, Thijs LG, Hack CE.
    J Clin Invest; 1989 Aug 04; 84(2):443-50. PubMed ID: 2668333
    [Abstract] [Full Text] [Related]

  • 7. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
    Martínez-Brotóns F, Oncins JR, Mestres J, Amargós V, Reynaldo C.
    Thromb Haemost; 1987 Aug 04; 58(2):709-13. PubMed ID: 3672421
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T, Ohno Y, Shimada T, Kato H, Iwanaga S.
    Adv Exp Med Biol; 1983 Aug 04; 156():87-107. PubMed ID: 6602465
    [Abstract] [Full Text] [Related]

  • 9. The plasma bradykinin-forming pathways and its interrelationships with complement.
    Kaplan AP, Ghebrehiwet B.
    Mol Immunol; 2010 Aug 04; 47(13):2161-9. PubMed ID: 20580091
    [Abstract] [Full Text] [Related]

  • 10. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K, Tholanikunnel BG, Bygum A, Ghebrehiwet B, Kaplan AP.
    J Allergy Clin Immunol; 2013 Aug 04; 132(2):470-5. PubMed ID: 23672780
    [Abstract] [Full Text] [Related]

  • 11. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE, Sidelmann JJ, Biltoft D, Gram J, Hansen S.
    Biochim Biophys Acta; 2015 Jun 04; 1850(6):1336-42. PubMed ID: 25800206
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional characterization of factor XII.
    Tans G, Rosing J.
    Semin Thromb Hemost; 1987 Jan 04; 13(1):1-14. PubMed ID: 3551074
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.
    Cugno M, Nuijens J, Hack E, Eerenberg A, Frangi D, Agostoni A, Cicardi M.
    J Clin Invest; 1990 Apr 04; 85(4):1215-20. PubMed ID: 2318974
    [Abstract] [Full Text] [Related]

  • 16. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM, Eisele B, de Jong IW, Chang A, Delvos U, Taylor FB, Hack CE.
    J Immunol; 1998 Jan 01; 160(1):475-84. PubMed ID: 9552006
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO, Erichsen NS, Gallimore MJ, Amundsen E.
    Adv Shock Res; 1980 Jan 01; 4():1-10. PubMed ID: 6172027
    [Abstract] [Full Text] [Related]

  • 20. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B, Tran TH, Ritz R, Duckert F.
    Am J Clin Pathol; 1984 Oct 01; 82(4):396-404. PubMed ID: 6206713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.